202 related articles for article (PubMed ID: 20153754)
1. A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
Genovese S; Foreman JE; Borland MG; Epifano F; Gonzalez FJ; Curini M; Peters JM
Life Sci; 2010 Mar; 86(13-14):493-8. PubMed ID: 20153754
[TBL] [Abstract][Full Text] [Related]
2. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
[TBL] [Abstract][Full Text] [Related]
3. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
[TBL] [Abstract][Full Text] [Related]
4. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
[TBL] [Abstract][Full Text] [Related]
5. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
[TBL] [Abstract][Full Text] [Related]
6. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
[TBL] [Abstract][Full Text] [Related]
7. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
[TBL] [Abstract][Full Text] [Related]
8. Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.
Peters JM; Kim DJ; Bility MT; Borland MG; Zhu B; Gonzalez FJ
Mol Carcinog; 2019 Sep; 58(9):1612-1622. PubMed ID: 31062422
[TBL] [Abstract][Full Text] [Related]
9. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
Bility MT; Devlin-Durante MK; Blazanin N; Glick AB; Ward JM; Kang BH; Kennett MJ; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Dec; 29(12):2406-14. PubMed ID: 18799709
[TBL] [Abstract][Full Text] [Related]
10. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
[TBL] [Abstract][Full Text] [Related]
11. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins.
Di-Poï N; Desvergne B; Michalik L; Wahli W
J Biol Chem; 2005 Nov; 280(46):38700-10. PubMed ID: 16166081
[TBL] [Abstract][Full Text] [Related]
14. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.
Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C
J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
Bedu E; Wahli W; Desvergne B
Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822
[TBL] [Abstract][Full Text] [Related]
17. Δ
Hirao-Suzuki M; Takeda S; Watanabe K; Takiguchi M; Aramaki H
Arch Biochem Biophys; 2019 Feb; 662():219-225. PubMed ID: 30553767
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
Yao PL; Chen L; Dobrzański TP; Zhu B; Kang BH; Müller R; Gonzalez FJ; Peters JM
Mol Carcinog; 2017 May; 56(5):1472-1483. PubMed ID: 27996177
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
[TBL] [Abstract][Full Text] [Related]
20. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.
Foreman JE; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Cancer Lett; 2010 Feb; 288(2):219-25. PubMed ID: 19660859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]